SHAREHOLDER ALERT: Levi & Korsinsky, LLP Announces an Investigation Involving Possible Securities Fraud Violations by Trinity...
October 05 2016 - 5:04PM
Business Wire
Levi & Korsinsky, LLP announces that it has commenced an
investigation of Trinity Biotech plc (“Trinity” or the “Company”)
(NASDAQ:TRIB) concerning possible violations of federal securities
laws by the Company and/or certain of its officers and
directors.
On October 4, 2016, Trinity revealed that it was withdrawing its
510(k) premarket notification submission for the Meritas Troponin-I
Test and Meritas Point-of-Care Analyzer, following the U.S. Food
and Drug Administration’s advice. Trinity also said it would
decrease its spending by roughly 85%, to $1.5 million from $9
million each year, and that it would close its Swedish facility,
eliminating 40 jobs. Following this news, Trinity stock dropped
$6.53 per share, more than 50 percent, to close at $6.46 on October
4, 2016. To obtain additional information about the investigation,
go to:
http://zlk.9nl.com/trinity-biotech-trib
or contact Joseph E. Levi, Esq. either via email at
jlevi@zlk.com or by telephone at (212) 363-7500, toll-free: (877)
363-5972.
Levi & Korsinsky is a national firm with offices in New
York, New Jersey, Connecticut and Washington D.C. The firm’s
attorneys have extensive expertise in prosecuting securities
litigation involving financial fraud, representing investors
throughout the nation in securities and shareholder lawsuits.
Attorney advertising. Prior results do not guarantee similar
outcomes.
View source
version on businesswire.com: http://www.businesswire.com/news/home/20161005006470/en/
Levi & Korsinsky, LLPJoseph E. Levi, Esq., 212-363-7500Toll
Free: (877) 363-5972Fax: (212) 363-7171www.zlk.com
Trinity Biotech (NASDAQ:TRIB)
Historical Stock Chart
From Mar 2024 to Apr 2024
Trinity Biotech (NASDAQ:TRIB)
Historical Stock Chart
From Apr 2023 to Apr 2024